Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,749.01
(
0.33%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mskatiescarletohara post# 36983

Tuesday, 11/07/2006 9:46:17 AM

Tuesday, November 07, 2006 9:46:17 AM

Post# of 257267
> ANDS may not meet their objective in this new study.<

The current CEO won’t be around to find out—how convenient. If ANA975 does make it back to the clinic, it will be in 2H07 at the earliest. It’s pretty hard to see how this compound will be a factor in the HCV arena.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today